Rob, F., Gkalpakiotis, S., Kojanová, M., Vantuchová, Y., Čelakovská, J., Horažďovský, J., . . . Třešňák Hercogová, J. (2025). Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry. Journal of the European Academy of Dermatology & Venereology, 39(12), e1056. https://doi.org/10.1111/jdv.70009
Παραπομπή σε μορφή Chicago (17η εκδ.)Rob, Filip, et al. "Efficacy and Safety of Lebrikizumab in Atopic Dermatitis over 24 weeks: An Analysis from the BIOREP Registry." Journal of the European Academy of Dermatology & Venereology 39, no. 12 (2025): e1056. https://doi.org/10.1111/jdv.70009.
Παραπομπή σε μορφή MLA (9th εκδ.)Rob, Filip, et al. "Efficacy and Safety of Lebrikizumab in Atopic Dermatitis over 24 weeks: An Analysis from the BIOREP Registry." Journal of the European Academy of Dermatology & Venereology, vol. 39, no. 12, 2025, p. e1056, https://doi.org/10.1111/jdv.70009.